尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by D'Silva Andrew J.. Director active across 1 company, notably OptimizeRx Corp. In total, 6 disclosures have been logged. History available since 21 August 2025. The latest transaction was filed on 21 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
D'Silva Andrew J. is a declarant linked to OptimizeRx Corp, where the listed function is Chief Business Officer. The 4 known filings, all in the recent sample from 2025-10-07 to 2025-12-22, concern tax withholding, with amounts of EUR 10407.4755813301, EUR 8099.77836346183, and EUR 6696.506380089 among the top filings.